ATE173252T1 - Arylmorpholine, herstellung und verwendung - Google Patents

Arylmorpholine, herstellung und verwendung

Info

Publication number
ATE173252T1
ATE173252T1 AT92908819T AT92908819T ATE173252T1 AT E173252 T1 ATE173252 T1 AT E173252T1 AT 92908819 T AT92908819 T AT 92908819T AT 92908819 T AT92908819 T AT 92908819T AT E173252 T1 ATE173252 T1 AT E173252T1
Authority
AT
Austria
Prior art keywords
preparation
human
morpholines
aryl
aryl morpholines
Prior art date
Application number
AT92908819T
Other languages
English (en)
Inventor
Nariman Bomanshaw Mehta
Grady Evan Boswell
James Leroy Kelley
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE173252T1 publication Critical patent/ATE173252T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92908819T 1991-04-23 1992-04-22 Arylmorpholine, herstellung und verwendung ATE173252T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108629A GB9108629D0 (en) 1991-04-23 1991-04-23 Heterocyclic pharmaceutical compounds,preparation and use

Publications (1)

Publication Number Publication Date
ATE173252T1 true ATE173252T1 (de) 1998-11-15

Family

ID=10693740

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92908819T ATE173252T1 (de) 1991-04-23 1992-04-22 Arylmorpholine, herstellung und verwendung

Country Status (17)

Country Link
US (2) US5648347A (de)
EP (1) EP0583271B1 (de)
JP (1) JP3130040B2 (de)
AT (1) ATE173252T1 (de)
AU (1) AU668863B2 (de)
CA (1) CA2108967C (de)
DE (1) DE69227583T2 (de)
DK (1) DK0583271T3 (de)
ES (1) ES2124256T3 (de)
FI (1) FI934680A0 (de)
GB (1) GB9108629D0 (de)
HU (1) HU219458B (de)
IE (1) IE921260A1 (de)
NZ (1) NZ242421A (de)
PT (1) PT100415B (de)
WO (1) WO1992018489A1 (de)
ZA (1) ZA922910B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
ATE365042T1 (de) 1998-01-21 2007-07-15 Glaxo Group Ltd Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
US7098206B2 (en) 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) * 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
FR2796069B3 (fr) * 1999-07-09 2001-08-24 Sanofi Synthelabo Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes
RS51442B (en) * 2002-12-10 2011-04-30 Pfizer Inc. MORPHOLINE DERIVATIVES USED AS DOPAMINE AGONISTS IN TREATMENT I.A. SEXUAL DYSFUNCTIONS
US7323462B2 (en) 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
GB0228787D0 (en) * 2002-12-10 2003-01-15 Pfizer Ltd Morpholine dopamine agonists
CA2800220C (en) * 2010-05-21 2019-04-30 Research Triangle Institute Phenylmorpholines and analogues thereof
JP5952267B2 (ja) 2010-05-21 2016-07-13 リサーチ・トライアングル・インスティチュート 薬物依存を処置するためのヒドロキシブプロピオン類似体（政府支援研究または開発）
CN105949142B (zh) * 2016-05-21 2018-03-27 南华大学 具有抗抑郁活性的单一手性化合物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997469A (en) * 1961-08-22 Preparation of substituted
GB851311A (en) * 1958-04-02 1960-10-12 Geigy Ag J R Morpholine compounds and their production
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
GB1336732A (en) * 1970-10-28 1973-11-07 Istituto Gentili Spa Pisa Diethanolamine derivatives
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
FR2517305B1 (fr) * 1981-12-01 1985-10-25 Lafon Labor Nouveaux derives de 2-phenyl-morpholine et leur utilisation en therapeutique
FR2553410B1 (fr) * 1983-10-14 1986-05-16 Lafon Labor Nouveaux derives de 2-tolyl-morpholine utiles en therapeutique
FR2553411B1 (fr) * 1983-10-14 1986-08-01 Lafon Labor Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8417170D0 (en) * 1984-07-05 1984-08-08 Wellcome Found Heterocyclic pharmaceutical compounds
US4803200A (en) * 1987-10-02 1989-02-07 A. H. Robins Company, Incorporated Substituted dialkanolamines, sulfur analogs and condensed 1,4-oxazine derivatives thereof in viral disease treatment
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use

Also Published As

Publication number Publication date
FI934680A (fi) 1993-10-22
US5648347A (en) 1997-07-15
CA2108967C (en) 2002-10-08
DE69227583T2 (de) 1999-04-01
EP0583271B1 (de) 1998-11-11
FI934680A0 (fi) 1993-10-22
HUT70531A (en) 1995-10-30
NZ242421A (en) 1994-10-26
AU1575392A (en) 1992-11-17
PT100415A (pt) 1993-06-30
ES2124256T3 (es) 1999-02-01
IE921260A1 (en) 1992-11-04
JPH06506675A (ja) 1994-07-28
DK0583271T3 (da) 1999-07-26
HU219458B (hu) 2001-04-28
GB9108629D0 (en) 1991-06-12
HU9303000D0 (en) 1994-01-28
CA2108967A1 (en) 1992-10-24
PT100415B (pt) 1999-08-31
ZA922910B (en) 1994-01-24
AU668863B2 (en) 1996-05-23
WO1992018489A1 (en) 1992-10-29
JP3130040B2 (ja) 2001-01-31
EP0583271A1 (de) 1994-02-23
DE69227583D1 (de) 1998-12-17
US5760224A (en) 1998-06-02

Similar Documents

Publication Publication Date Title
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE69523169D1 (de) Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung
SE9604786D0 (sv) New compounds
ATE189601T1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
ATE173252T1 (de) Arylmorpholine, herstellung und verwendung
DE69428325D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
DE69426855T2 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung des Knorpelabbaus
ATE2265T1 (de) Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
DE69501359T2 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
ES2104938T3 (es) Metodo de inhibir la fibrosis.
SE8000085L (sv) Cis och trans-3-aryloxi-4-hydroxipyrrolidiner och derivater derav
ES550742A0 (es) Un procedimiento para la preparacion de una octahidroindo- lizina
ATE240101T1 (de) Verwendung von 2-phenyl-3- aroylbenzothiophenderivaten zur herstellung eines medikaments zur knochen- und bruchheilung
NO950177D0 (no) Farmakologisk aktive erivater
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
SE9603284D0 (sv) New compounds
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
ATE179890T1 (de) Verwendung von benzothiophenen zur herstellung eines medikaments zur verminderung der narbenbildung bei der wundheilung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee